Elizabeth Wang, MD
Dermatology · San Mateo, CANPI 1043695174
Payments from drug & device makers
Across 115 payments — averaging $32.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Galderma Laboratories, L.p.$462
- Incyte Corporation$396
- Regeneron Healthcare Solutions, Inc.$380
- Lilly USA, LLC$252
- Arcutis Biotherapeutics, Inc.$228
- plus $795 from 12 others
What the payments were for
- Travel & lodging$1855%
- Food & beverage$3,37892%
- Education$1213%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $1,169 |
| Galderma Laboratories, L.p. | 11 | $462 |
| Incyte Corporation | 7 | $396 |
| Regeneron Healthcare Solutions, Inc. | 10 | $380 |
| Lilly USA, LLC | 10 | $252 |
| Arcutis Biotherapeutics, Inc. | 14 | $228 |
| Sanofi | 8 | $205 |
| UCB, Inc. | 6 | $148 |
| Revance Therapeutics, Inc. | 4 | $83 |
| Pfizer | 4 | $78 |
| LEO Pharma Inc. | 3 | $65 |
| Novartis | 2 | $51 |
| Merz North America, Inc. | 1 | $33 |
| Organon | 1 | $31 |
| Surgenex LLC | 1 | $30 |
| Sun Pharmaceutical Industries Inc. | 1 | $30 |
| Dermavant Sciences, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPZELURA$259
- NATRELLE SALINE-FILLED BREAST IMPLANTS$185
- NEMLUVIO$129
- Rinvoq$128
- Skyrizi$125
How this compares
$3,683 in reported general payments places this provider in the 60th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $60,694 |
| Fluorouracil | 23 | $2,174 |
| Clobetasol Propionate | 49 | $2,099 |
| Ketoconazole | 74 | $1,101 |
| Dutasteride | 15 | $1,068 |
| Tretinoin | 15 | $849 |
| Metronidazole | 19 | $786 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 15 | $597 |
| Triamcinolone Acetonide | 53 | $544 |
| Doxycycline Monohydrate | 26 | $413 |
| Fluocinonide | 20 | $374 |
| Minoxidil | 28 | $347 |
| Mupirocin | 49 | $336 |
| Hydrocortisone | 41 | $137 |
| Finasteride | 15 | $132 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Mateo
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
- April ArmstrongLos Angeles$6.2M
- David RayhanHuntington Beach$5.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.